Article
ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium.
Oncology reports - 1 Apr 2013
Rizzato Cosmeri, Campa Daniele, Pezzilli Raffaele, Soucek Pavel, Greenhalf William, Capurso Gabriele, Talar-Wojnarowska Renata, Heller Anette, Jamroziak Krzysztof, Khaw Kay-Tee, Key Tim J, Bambi Franco, Landi Stefano, Mohelnikova-Duchonova Beatrice, Vodickova Ludmila, Büchler Markus W, Bugert Peter, Vodicka Pavel, Neoptolemos John P, Werner Jens, Hoheisel Jörg D, Bauer Andrea S, Giese Nathalia, Canzian Federico
Abstract excerpt
There is strong epidemiologic evidence indicating that common genetic variability could be implicated in pancreatic cancer risk and, to date, various loci have been proposed. In particular, there is increasing evidence of the involvement of ABO gene variability and pancreatic cancer risk. In a large multicentric study of 1,028 pancreatic ductal adenocarcinoma cases...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
